Skip to page content

Antimicrobial Resistance

Featured

Commentary
Europe's Fight Against Antimicrobial Resistance
The EC's AMR Action Plan included measures to ensure antimicrobials are used more appropriately in both humans and animals and measures to stimulate R&D of new antibiotics. One area that was not sufficiently covered was the environment.
Nov 3, 2016
Report
The Economic Costs of Antimicrobial Resistance
More and more bacterial and viral infections are resistant to antimicrobial drugs. But no new classes of antibiotics have entered the market for more than 25 years. Researchers estimate that failing to address this issue will mean a lower world population in 2050 than expected and at least $2 trillion in lost global GDP.
Dec 11, 2014

Explore Antimicrobial Resistance

Journal Article
Study on a Future-Proofing Analysis of the 2017 EU AMR Action Plan
This preliminary outcome assessment and future-proofing study of the 2017 European One Health Action Plan against Antimicrobial Resistance (AMR) identifies priorities to inform improvements that can make the EU AMR Action Plan fit for the future.
Jan 19, 2023
Brochure
Spotlight 2021–2022
Spotlight 2021-2022 highlights selected RAND Europe projects that address the important issues of our time. It also features research that is poised to make a difference in the coming year.
Feb 23, 2022
Journal Article
Progress Report: AMR Industry Alliance 2021 Survey
An analysis of AMR Industry Alliance contributions to the fight against antimicrobial resistance.
Feb 1, 2022
Journal Article
A Rapid Evidence Assessment Exploring Whether Antimicrobial Resistance Complicates Non-Infectious Health Conditions and Healthcare Services, 2010–20
This study explored what impact AMR is currently having on non-communicable health conditions, or areas of health services, via a rapid evidence assessment of 101 studies.
Dec 3, 2021
Journal Article
How Is Modern Medicine Being Affected by Drug-Resistant Infections?
This report explores the relationship between drug-resistant bacterial infections, focusing on antibiotic-resistant infections and conditions such as HIV, cancer and diabetes and medical treatment including surgery, organ transplant and ICU care.
Sep 28, 2021
Blog
Medicare, Climate Change, 'Superbugs': RAND Weekly Recap
This weekly recap focuses on opening Medicare to Americans at age 50, how to assess climate change plans, antibiotic-resistant
Nov 22, 2019
Journal Article
When Antibiotics Fail: The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada
Researchers examined the current impacts of AMR on Canada's healthcare system, the future impact on Canada's GDP, and how widespread resistance could influence the day-to-day lives of Canadians.
Nov 21, 2019
Journal Article
Isolation Precautions Use for Multidrug-Resistant Organism Infection in Nursing Homes
To examine factors associated with isolation precaution use in nursing home (NH) residents with multidrug-resistant organism (MDRO) infection.
Mar 28, 2017
Journal Article
Antibiotics Prescribed as Often During Telemedicine Appointments as In-Person Visits
Patients treated for acute respiratory infections by a doctor on a telephone or live video are as likely to be prescribed an antibiotic as those treated in person. However, patients treated virtually are more often prescribed a broad-spectrum antibiotic, which is concerning because overuse of the drugs increases costs and contributes to antibiotic resistance.
Mar 28, 2017
Brochure
Spotlight on 2016
Spotlight, RAND Europe's annual review, features ways that our objective research and analysis expanded perspectives in 2016 to provide policy and decision makers the evidence and facts during a year of highly charged political debates.
Dec 31, 2016
Journal Article
Evaluation of the Action Plan Against the Rising Threats from Antimicrobial Resistance
This report presents an evaluation of the European Commission's 'Communication to the European Parliament and the Council on the Action Plan against the Rising Threats from Antimicrobial Resistance.'
Nov 4, 2016
News Release
More Support for Individual Member States Is Needed to Tackle AMR in Europe
An evaluation of the European Commission's Action Plan against antimicrobial resistance (AMR) has shown that individual member states need more help with developing and implementing their own action plans. A one-size-fits-all approach is insufficient when dealing with the diverse challenges in each country.
Nov 3, 2016
Research Brief
Europe's plan to tackle antimicrobial resistance: The success stories and challenges
This brief presents a brief summary of findings from an evaluation of the European Commission's "Evaluation of the EC Action Plan against the rising threats from antimicrobial resistance."
Nov 3, 2016
Journal Article
Evaluation of the EC Action Plan Against the Rising Threats from Antimicrobial Resistance: Final Report - Appendices
This set of appendices supplements the final report for the 'Evaluation of the EC Action Plan against the rising threats from antimicrobial resistance'.
Nov 3, 2016
Commentary
Why the UN General Assembly Session on AMR Matters
Many common infections are becoming resistant to the antimicrobial medicines used to treat them, resulting in longer illnesses and more deaths. The fact that world leaders are using the UN as a forum for discussions about antimicrobial resistance is a promising move toward developing a coordinated global plan.
Sep 19, 2016
Commentary
European and American Efforts to Tackle AMR: Great Minds Think Alike (Almost Always)
The United States and the European Union are committed to tackling antimicrobial resistance. Their efforts share objectives around key areas for improvement, such as the stewardship of existing antimicrobials, surveillance of their use, and development of new antimicrobials.
Aug 19, 2016
Commentary
The Rio Olympics Are the Site of a Battle Against 'Super Bacteria'
Brazilian scientists detected drug-resistant bacteria growing off some of Rio de Janeiro's beaches, close to where it will host sailing and wind-surfing events, and in the lagoon where the rowing and canoeing events will take place.
Jul 29, 2016
Commentary
The Global Economic Costs of Antimicrobial Resistance
In addition to being a public health problem, antimicrobial resistance is also a major economic concern. It crosses sectoral boundaries, because resistant bugs can pass between animals and humans, and through food, agriculture, and the environment.
May 20, 2016
Commentary
The O'Neill Review: A Critical Step in Taking Global Action Against AMR
The O'Neill Review aims to increase global knowledge of antimicrobial resistance (AMR) and generate international consensus about the nature of the problem and the necessary steps to tackle it. A RAND Europe analysis of the potential economic costs of AMR contributed to the Review.
May 19, 2016

1
2
Next

RAND Topic:
Antimicrobial Resistance

Topic Synonyms:
AMR